Re: 'A threefold dose intensity treatment with ifosfamide, carboplatin, and etoposide for patients with small-cell lung cancer: a randomized trial'

J Natl Cancer Inst. 2009 Jan 7;101(1):67; author reply 67-8. doi: 10.1093/jnci/djn406. Epub 2008 Dec 30.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Antineoplastic Agents, Alkylating / administration & dosage
  • Antineoplastic Agents, Phytogenic / administration & dosage
  • Antineoplastic Combined Chemotherapy Protocols / administration & dosage
  • Antineoplastic Combined Chemotherapy Protocols / adverse effects
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Carboplatin / administration & dosage
  • Clinical Trials, Phase III as Topic
  • Drug Administration Schedule
  • Etoposide / administration & dosage
  • Humans
  • Ifosfamide / administration & dosage
  • Lung Neoplasms / drug therapy*
  • Multicenter Studies as Topic
  • Randomized Controlled Trials as Topic
  • Research Design
  • Small Cell Lung Carcinoma / drug therapy*
  • Treatment Outcome

Substances

  • Antineoplastic Agents, Alkylating
  • Antineoplastic Agents, Phytogenic
  • Etoposide
  • Carboplatin
  • Ifosfamide